Group One Trading, L.P. Nkarta, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $3,666 - $18,473	2,799 Added 173.31%	4,414 $29,000
Q3 2023 Nov 09, 2023	SELL	$1.39 - $2.29 $618 - $1,019	-445 Reduced 21.6%	1,615 $2,000
Q2 2023 Aug 09, 2023	SELL	$2.19 - $5.17 $2,369 - $5,593	-1,082 Reduced 34.44%	2,060 $4,000
Q1 2023 May 12, 2023	BUY	$3.37 - $6.3 $10,588 - $19,794	3,142 New	3,142 $11,000
Q4 2021 Feb 11, 2022	SELL	$12.79 - $26.88 $1,279 - $2,688	-100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$26.67 - $38.76 $2,667 - $3,876	100 New	100 $3,000

126

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $116M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.